Advisors Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Sell |
11,543
-13,237
| -53% | -$153K | ﹤0.01% | 1165 |
|
|
2025
Q1 | $216K | Sell |
24,780
-805
| -3% | -$7.03K | ﹤0.01% | 1098 |
|
|
2024
Q4 | $367K | Sell |
25,585
-1,232
| -5% | -$17.7K | 0.01% | 995 |
|
|
2024
Q3 | $606K | Sell |
26,817
-674
| -2% | -$15.2K | 0.01% | 871 |
|
|
2024
Q2 | $535K | Buy |
27,491
+2,263
| +9% | +$44K | 0.01% | 875 |
|
|
2024
Q1 | $947K | Buy |
25,228
+5,406
| +27% | +$203K | 0.02% | 752 |
|
|
2023
Q4 | $1.11M | Buy |
19,822
+9,357
| +89% | +$524K | 0.02% | 699 |
|
|
2023
Q3 | $432K | Buy |
10,465
+2,903
| +38% | +$120K | 0.01% | 936 |
|
|
2023
Q2 | $422K | Buy |
7,562
+562
| +8% | +$31.4K | 0.01% | 979 |
|
|
2023
Q1 | $391K | Sell |
7,000
-750
| -10% | -$41.8K | 0.01% | 987 |
|
|
2022
Q4 | $282K | Sell |
7,750
-11,549
| -60% | -$421K | 0.01% | 1073 |
|
|
2022
Q3 | $550K | Sell |
19,299
-1,143
| -6% | -$32.6K | 0.01% | 906 |
|
|
2022
Q2 | $925K | Sell |
20,442
-573
| -3% | -$25.9K | 0.02% | 781 |
|
|
2022
Q1 | $1.6M | Sell |
21,015
-874
| -4% | -$66.5K | 0.02% | 659 |
|
|
2021
Q4 | $3.26M | Buy |
21,889
+2,435
| +13% | +$363K | 0.05% | 446 |
|
|
2021
Q3 | $2.83M | Buy |
19,454
+3,847
| +25% | +$560K | 0.04% | 465 |
|
|
2021
Q2 | $3.06M | Buy |
15,607
+4,922
| +46% | +$964K | 0.05% | 449 |
|
|
2021
Q1 | $1.93M | Buy |
10,685
+6,134
| +135% | +$1.11M | 0.03% | 606 |
|
|
2020
Q4 | $644K | Buy |
+4,551
| New | +$644K | 0.01% | 899 |
|